GEN Exclusives

More »

GEN News Highlights

More »
Oct 16, 2008

IDT Inks Probe Manufacturing License with Applied Biosystems

  • Integrated DNA Technologies (IDT) obtained a probe manufacturing license from Applied Biosystems to sell dual-labeled probes for use in the 5’ Nuclease process, a technique for real-time PCR.

    The license will make it possible for IDT to offer design services for probes and primers for use in the assay and to supply researchers with the resulting probes and primers in a more convenient, ready-to-use format, according to the firms.

    Customers will thus be able to purchase probes from IDT that are licensed for use in the 5’ Nuclease Assay. Currently, researchers purchase probes and primers in separate tubes, and often from separate vendors that disclaim any licensed right of the customer to use the probes in the 5’ Nuclease Assay.

    Applied Biosystems’ probe manufacturing license program grants licensees rights to make and sell custom oligonucleotides and oligonucleotide sets for use in the 5’ Nuclease process under patents owned by both Applied Biosystems and Roche.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?